Department of Systems Immunology, College of Biomedical Science, Kangwon National University, Chuncheon, Gangwon 200-701, South Korea.
Immunol Lett. 2010 Nov 30;134(1):55-61. doi: 10.1016/j.imlet.2010.08.009. Epub 2010 Aug 24.
Specific antibodies that possess a subnanomolar affinity are very difficult to obtain from human naïve immunoglobulin repertoires without the use of lengthy affinity optimization procedures. Here, we designed a hierarchical phage-displayed antibody library system to generate an enormous diversity of combinatorial Fab fragments (6×10(17)) and attempted to isolate high-affinity Fabs against the human epidermal growth factor receptor (EGFR). A primary antibody library, designated HuDVFab-8L, comprising 4.5×10(9) human naïve heavy chains and eight unspecified human naïve light chains was selected against the EGFR-Fc protein by biopanning, and four anti-EGFR Fab clones were isolated. Because one of the Fab clones, denoted EG-L2-11, recognized a native EGFR expressed on A431 cells, the heavy chain of the Fab was shuffled with a human naïve light chain repertoire with a diversity of 1.4×10(8) and selected a second time against the EGFR-Fc protein again. One EG-L2-11 variant, denoted EG-19-11, recognized an EGFR epitope that was almost the same as that bound by cetuximab and had a K(D) of approximately 540 pM for soluble EGFR, which is about 7-fold higher than that of the FabC225 derived from cetuximab. This variant was also internalized by A431 cells, likely via receptor-mediated endocytosis, and it efficiently inhibited EGF-mediated tyrosine phosphorylation of the EGFR. These results demonstrate that the use of our hierarchical antibody library system is advantageous in generating fully human antibodies especially with a therapeutic purpose.
特定的具有亚纳摩尔亲和力的抗体非常难以从人类天然免疫球蛋白库中获得,而无需使用冗长的亲和力优化程序。在这里,我们设计了一种分层噬菌体展示抗体文库系统,以产生大量的组合 Fab 片段(6×10(17)),并试图分离针对人表皮生长因子受体(EGFR)的高亲和力 Fab。一个初级抗体文库,命名为 HuDVFab-8L,包含 4.5×10(9)个人类天然重链和八个未指定的人类天然轻链,通过生物淘选针对 EGFR-Fc 蛋白进行选择,分离出四个抗 EGFR Fab 克隆。由于其中一个 Fab 克隆,命名为 EG-L2-11,识别 A431 细胞上表达的天然 EGFR,因此该 Fab 的重链与多样性为 1.4×10(8)的人类天然轻链库进行改组,并再次针对 EGFR-Fc 蛋白进行第二次选择。一个 EG-L2-11 变体,命名为 EG-19-11,识别与西妥昔单抗结合的 EGFR 表位几乎相同,对可溶性 EGFR 的 K(D)约为 540 pM,比西妥昔单抗衍生的 FabC225 高约 7 倍。该变体也被 A431 细胞内化,可能通过受体介导的内吞作用,并且有效地抑制了 EGF 介导的 EGFR 酪氨酸磷酸化。这些结果表明,使用我们的分层抗体文库系统在产生特别是具有治疗目的的全人抗体方面具有优势。